The changes follow a March 2023 meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs...
A retrospective analysis of US Department of Veterans Affairs data examined whether thiazide diuretic prescribing patterns met 2017 American...
Diagnosis is often difficult because early signs and symptoms, such as fever and swollen lymph nodes, may be present without evidence of a rash....
To support clinicians in diagnosing and managing DRESS, a steering committee conducted a literature review to examine current research, identify...
Efbemalenograstim has been approved by the FDA to combat infections in adults being treated for nonmyeloid cancers.
Adverse event data showed an increased risk of myelosuppression, sepsis, pneumotoxic effects, or hepatotoxic effects.
“Clinicians should be vigilant in monitoring signs and symptoms of cardiovascular diseases, particularly among those receiving higher doses.”
Complete responses continued to increase in open-label extensions of phase 3 alopecia areata studies.
Tapinarof cream, 1%, an aryl hydrocarbon receptor agonist, was approved in 2022 for treating plaque psoriasis in adults.
In two studies run in parallel fashion, testing different strategies, automatic referral to a pharmacist was superior to EHR alerts for increasing...